MiR-613 suppresses retinoblastoma cell proliferation, invasion, and tumor formation by targeting E2F5

被引:16
|
作者
Zhang, Yiting [1 ]
Zhu, Xinyue [1 ]
Zhu, Xiaomin [2 ]
Wu, Yan [2 ]
Liu, Yajun [1 ]
Yao, Borui [1 ]
Huang, Zhenping [1 ]
机构
[1] Nanjing Univ, Jinling Hosp, Med Sch, Dept Ophthalmol, Nanjing 210002, Jiangsu, Peoples R China
[2] Jinling Hosp, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Retinoblastoma; miR-613; E2F5; HEPATOCELLULAR-CARCINOMA; PATHWAY; CANCER; MICRORNAS; OVEREXPRESSION; CHEMOREDUCTION; EXPRESSION; FAMILY; GROWTH;
D O I
10.1177/1010428317691674
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Retinoblastoma is a common intraocular malignancy that occurs during childhood. MicroRNAs play critical roles in the regulation of retinoblastoma initiation and progression, and aberrant expression of miR-613 had been reported in various types of cancer. However, the role and mechanism of its function in retinoblastoma are still unclear. In this study, we found that miR-613 was downregulated in retinoblastoma tissues and cell lines. Overexpression of miR-613 suppressed retinoblastoma cell proliferation, migration, and invasion and induced cell cycle arrest in vitro. Additionally, overexpressed miR-613 also inhibited tumor formation of retinoblastoma cells in vivo. We further identified E2F5 as a direct target of miR-613. Reintroduction of E2F5 without 3'-untranslated region reversed the inhibitory effects of miR-613 on cell proliferation and invasion. Our data collectively indicate that miR-613 functions as a tumor suppressor in retinoblastoma through downregulating E2F5, supporting the targeting of the novel miR-613/E2F5 axis as a potentially effective therapeutic approach for retinoblastoma.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [21] miR-132 inhibits high glucose-induced vascular smooth muscle cell proliferation and migration by targeting E2F5
    Xu, Qun
    Liang, Ying
    Liu, Xiangjuan
    Zhang, Chunmei
    Liu, Xiaoqian
    Li, Hong
    Liang, Jiangjiu
    Yang, Guang
    Ge, Zhiming
    MOLECULAR MEDICINE REPORTS, 2019, 20 (02) : 2012 - 2020
  • [22] MiR-142-5p promotes retinoblastoma cell proliferation, migration and invasion by targeting PTEN
    Zhang, Yujie
    Zheng, Ailing
    JOURNAL OF BIOCHEMISTRY, 2021, 170 (02): : 195 - 202
  • [23] miR-365 Suppresses Cholangiocarcinoma Cell Proliferation and Induces Apoptosis by Targeting E2F2
    Chen, Lunjian
    Huang, Xiaorong
    Chen, Xinxin
    ONCOLOGY RESEARCH, 2018, 26 (09) : 1375 - 1382
  • [24] RETRACTION: hsa_circ_0084811 Regulates Cell Proliferation and Apoptosis in Retinoblastoma through miR-18a-5p/miR-18b-5p/E2F5 Axis
    Jiang, G.
    Qu, M.
    Kong, L.
    Song, X.
    Jiang, S.
    BIOMED RESEARCH INTERNATIONAL, 2024, 2024
  • [25] 微小核糖核酸miR-613通过下调E2F5的表达抑制前列腺癌细胞增殖
    何岩
    韩广业
    刘沛
    李泽宇
    李建昌
    吴春磊
    现代泌尿外科杂志, 2019, 24 (10) : 859 - 864
  • [26] MiR-338 suppresses cell proliferation and invasion by targeting CTBP2 in glioma
    Liu, De-Zhi
    Zhao, Hui
    Zou, Qin-Guang
    Ma, Qing-Jie
    CANCER BIOMARKERS, 2017, 20 (03) : 289 - 297
  • [27] MiR-92a-2-5p suppresses esophageal squamous cell carcinoma cell proliferation and invasion by targeting PRDX2
    Zhan, Xiang
    Li, Jixian
    Zeng, Renya
    Lei, Lingli
    Feng, Alei
    Yang, Zhe
    EXPERIMENTAL CELL RESEARCH, 2024, 435 (01)
  • [28] miR-590-5p suppresses osteosarcoma cell proliferation and invasion via targeting KLF5
    Cai, Wei
    Xu, Yong
    Yin, Jian
    Zuo, Wenshan
    Su, Zhen
    MOLECULAR MEDICINE REPORTS, 2018, 18 (02) : 2328 - 2334
  • [29] MiR-544a Regulates Synovial Cell Proliferation, Invasion, Migration and Apoptosis by Targeting E2F2
    Pan, Lingxiao
    Gan, Kaifeng
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2019, 9 (08) : 1065 - 1072
  • [30] RETRACTION: miR-613 inhibits proliferation and invasion of breast cancer cell via VEGFA (Retraction of Vol 478, Pg 274, 2016)
    Wu, Junzhao
    Yuan, Peng
    Mao, Qixin
    Lu, Peng
    Xie, Tian
    Yang, Hanzhao
    Wang, Chengzheng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 515 (04) : 734 - 734